11 results about "Spermatogonium" patented technology

A sequential cell culture system and methods for the in vitro generation of human spermatozoa from differentiating spermatogonia (dSPGs) and spermatogonial stem cells (SSCs) is provided. The instant disclosure encompasses the discovery and optimization of distinct, stage-specific culture media and conditions that enable, for the first time, the complete progression of human spermatogenesis outside the body. The process includes: (1) inducing entry of dSPGs and SSCs into meiosis; (2) supporting meiotic progression and completion to round spermatids; and (3) promoting spermiogenesis and the formation of elongated, spermatozoa. The invention further provides compositions, systems, and protocols for each stage, as well as markers and methods for identifying successful progression through each developmental transition. This system enables, for the first time, the complete in vitro recapitulation of human spermatogenesis, providing a platform for research, infertility treatment, and assisted reproductive technologies.

The invention belongs to the technical field of medicines, and particularly discloses application of afzelin in preparation of an anti-testis aging medicament, and testis aging resistance is particularly improvement or recovery of an aged testis tissue structure. The invention also provides a medicament for resisting testis aging. The medicament contains afzelin. The invention provides a new application of afzelin, the afzelin can be used for saving senescence testicular tissue structure disorder, remarkably reducing the epididymal sperm deformation rate and increasing the number of supporting cells and undifferentiated spermatogonium cells, the new application value of afzelin is developed, and a theoretical basis is provided for developing afzelin into anti-reproductive aging drugs.

A sequential cell culture system and methods for the in vitro generation of human spermatozoa from differentiating spermatogonia (dSPGs) and spermatogonial stem cells (SSCs) is provided. The instant disclosure encompasses the discovery and optimization of distinct, stage-specific culture media and conditions that enable, for the first time, the complete progression of human spermatogenesis outside the body. The process includes: (1) inducing entry of dSPGs and SSCs into meiosis; (2) supporting meiotic progression and completion to round spermatids; and (3) promoting spermiogenesis and the formation of elongated, spermatozoa. The invention further provides compositions, systems, and protocols for each stage, as well as markers and methods for identifying successful progression through each developmental transition. This system enables, for the first time, the complete in vitro recapitulation of human spermatogenesis, providing a platform for research, infertility treatment, and assisted reproductive technologies.

The present disclosure provides bovine animals and methods to create recipient bovine animals for spermatogenic stem cell transplantation / complementation through modulation of the NANOS2 gene. In one embodiment genome editing was used to create bovine animals with insertions or deletions (indels) that inactivate or otherwise modulate NANOS2 gene activity so that resulting male bovines lack functional germ cells yet retain functional testicular somatic cells, and bovine females are fertile. These bovine males can then be transplanted or complemented with donor cells capable of giving rise to cells of the spermatogenic lineage, or spermatogenic stem cells and used for breeding.

The invention belongs to the field of basic medical research, and particularly relates to a testicular toxicity animal model establishing method which comprises the following steps: performing intragastric administration on male rats with a preparation containing podophyllotoxin according to the dosage of 15 mg / kg per day; the medicine is continuously administrated for 4 days; according to the method, the rat can be induced to generate testicular toxicity phenotypes, and the phenotypes at least include that the number of sperms is remarkably reduced, the activity of the sperms is reduced, the testosterone level of serum is abnormally increased, and spermatogenic tubules in testicular tissue are irregular in shape and spermatogenic epithelium is thinned.

An object of the present invention is to provide a method for simply and efficiently inducing differentiation of oogonia or prospermatogonia from primordial germ cell-like cells or primordial germ cells. The object is solved by a method for producing oogonia or prospermatogonia comprising a step of culturing primordial germ cell-like cells or primordial germ cells in a medium containing a BMP receptor type 2 signal activator to obtain oogonia or prospermatogonia.

The present application relates to the preparation and application field of biological peptide, and particularly relates to a plectinum peptide and application of the plectinum peptide in preparation of a product for repairing male reproductive system damage function. The present application utilizes green controllable enzymolysis technology to obtain protein polypeptides with nutritional health care and medicinal values, and further researches on the basis to obtain an active peptide sequence with high biological activity, obtains the active peptide with high purity through a chemical synthesis mode, and verifies the biological activity of the peptide by using mouse spermatogonia.

The invention provides a specific marker gene lhh2a. 2.2 of spermatogonium of larimichthys crocea as well as a screening method and application of the specific marker gene lhh2a. 2.2, and belongs to the field of molecular markers and the field of germline stem cell research. According to the invention, the nucleotide sequence of the lhh2a. 2.2 gene is as shown in SEQ ID NO: 1; through screening and analysis of a single cell transcription sequencing technology, and through in-situ hybridization, Vasa gene and PCNA gene co-localization, it is determined that the lhh2a. 2.2 gene can specifically identify spermatogonium in a proliferation state; a core tool and a prerequisite condition can be provided for establishment of a high-efficiency germ cell transplantation technology, purification of spermatogonial stem cells for in-vitro culture and construction of a transgenic pseudosciaena crocea strain.

The application relates to a kit for detecting the differentiation state of fruit fly testis spermatogonia and an application thereof, wherein the kit comprises reagents for detecting the expression level of a Bckdhb gene, the Bckdhb gene being a dominant expression gene in fruit fly testis tissue. By using a UAS / Gal4 system to specifically knock down Bckdhb in spermatogonia and driving the Bckdhb by Bam-Gal4, it is found that the down-regulation of the Bckdhb expression level can cause the spermatogonia differentiation to be blocked, the testis top nucleus deepening distance is increased, the germ cell differentiation is defective, meanwhile, the Bckdhb mRNA level is significantly decreased, and the Piwi mRNA level is significantly increased. The expression level of the Bckdhb can be detected to effectively judge the differentiation state of the spermatogonia. The kit provided by the application can be used for fruit fly testis spermatogonia differentiation research, and has important scientific research application value.

This invention discloses a rapid method for detecting calcium signals in undifferentiated and differentiated spermatogonia. The method uses a mild enzymatic digestion method to prepare a testicular single-cell suspension. Indo-1 AM, Thy-APC, and c-kit-PE are used for staining and labeling. The cell population to be analyzed is determined based on the difference between the lateral and forward scattering areas of the cells in the testicular cell sample. Then, Thy-APC and c-kit-PE are used to label undifferentiated and differentiated spermatogonia, respectively, to further select specific cell groups. Finally, the fluorescence intensity changes of indo-1 AM in each specific cell subpopulation are detected, thereby obtaining the changes in calcium ion concentration in undifferentiated, undifferentiated-to-differentiated, and differentiated spermatogonia. This method can rapidly analyze the calcium ion concentration in undifferentiated, undifferentiated-to-differentiated, and differentiated spermatogonia. The method is simple and convenient, and provides a foundation for identifying spermatogonial dysfunction caused by calcium signal imbalance.

The application discloses a method for efficiently inducing haploid sperms from Chinese Ophiocephalus sertifer primordial cells in vitro, and improves the efficiency of inducing primordial cells to generate functional sperms in vitro, and comprises the following steps: placing the primordial cells in a three-dimensional non-stent type culture material containing a sperm induction culture medium to culture; the sperm induction culture medium is obtained by adding sex hormones, melatonin and ERK1 / 2 activators into a basic sperm culture medium. The application further discloses a culture medium for efficiently inducing haploid sperms from Chinese Ophiocephalus sertifer primordial cells in vitro.